Asthma vs. COPD in Primary Care: Are We Missing Asthma-COPD Overlap?

Asthma vs. COPD in Primary Care Are We Missing Asthma-COPD Overlap Abstract Primary care physicians often encounter considerable difficulty when distinguishing between asthma and chronic obstructive pulmonary disease (COPD). Both conditions share overlapping respiratory symptoms such as cough, wheeze, and breathlessness, which can obscure diagnostic clarity and lead to

Salbutamol: A Safety Meta-Analysis

Salbutamol: A Safety Meta-Analysis Overview Salbutamol, a widely used bronchospasm reliever, has been insufficiently scrutinized for potential risks. In a meta-analysis of 58 randomized controlled trials with 12,961 participants, the study unearthed a 34% incidence of total adverse events (AEs). Notably, severe AEs stood at 2%, and treatment discontinuation was 3%. Subgroup

COPD Risk With Diabetes And Pre-Diabetes

COPD Risk With Diabetes And Pre-Diabetes A new trail-blazing study links diabetes, pre-diabetic states, and an extended duration of diabetes to an increased risk of chronic obstructive pulmonary disease development. This article will explore this ground-breaking research and its findings. Background of the Study Diabetes and chronic obstructive pulmonary diseases (COPD) are among

Asthma vs. COPD in Primary Care: Are We Missing Asthma-COPD Overlap?